About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
Gilead licenses generic version of Lenacapavir as PREP in 120 countries outside the U.S.Gilead licenses generic version of Lenacapavir as PREP in 120 countries outside the U.S.
October 2, 2024 |
Tahira Pratt
Activists urge the World Bank not to resume lending to Uganda
Related Posts
Access to Medicines
Pharma’s alleged “brea...
PEPFAR Watch
PEPFAR is Rolling the Cloc...
Access to Medicines
Pharma Pricing Secrecy Run...